{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T09:25:51Z","timestamp":1783416351566,"version":"3.54.6"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"21","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,5,22]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>This study aims to elucidate the genetically causal link between rheumatic diseases and idiopathic pulmonary fibrosis (IPF) using Mendelian randomization (MR) analysis. Genome-wide association studies data for IPF were sourced from the FINN cohort in the IEU database, rheumatoid arthritis (RA), systemic lupus erythematosus data, and Sj\u00f6gren syndrome data from the European Bioinformatics Institute, and ankylosing spondylitis data from Risteys FinnGen. We utilized single-nucleotide polymorphisms as instrumental variables using two-sample bidirectional MR analysis, which included MR-Egger, weighted median, weighted mode, and the inverse-variance weighting method. Sensitivity analysis involved various methods. Bidirectional MR analysis revealed suggestive evidence of an association between RA and IPF. After removal of outliers, the forward MR analysis showed a potential causal effect of RA on IPF using inverse-variance weighting (odds ratio [OR]\u2005=\u20051.24, 95% confidence interval [CI]\u2005=\u20051.09\u20131.42) and weighted median methods (OR\u2005=\u20051.27, 95% CI\u2005=\u20051.04\u20131.55), while MR-Egger and weighted mode analyses did not reach statistical significance. In addition, IPF was identified as a potential risk factor for RA (OR\u2005=\u20051.04, 95% CI\u2005=\u20051.01\u20131.07) and Sj\u00f6gren syndrome (OR\u2005=\u20051.23, 95% CI\u2005=\u20051.02\u20131.49). However, none of the observed associations remained significant after false discovery rate correction for multiple testing. Our analysis yields suggestive evidence of a potential genetic association between rheumatic diseases and IPF, highlighting the need for further investigation into the complex interplay between these conditions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000048543","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T17:00:40Z","timestamp":1779469240000},"page":"e48543","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Two-sample Mendelian randomization analysis unveils a potential genetic association between rheumatic diseases and the risk of idiopathic pulmonary fibrosis"],"prefix":"10.1097","volume":"105","author":[{"given":"Wei","family":"Tan","sequence":"first","affiliation":[{"name":"Department of Respiratory and Critical Care Medicine, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurong","family":"Ding","sequence":"additional","affiliation":[{"name":"Department of Emergency, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Emergency, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8361-6171","authenticated-orcid":false,"given":"Shanmei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Emergency, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260707","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/S2213-2600(23)00432-0","article-title":"Morphine for treatment of cough in idiopathic pulmonary fibrosis (PACIFY COUGH): a prospective, multicentre, randomised, double-blind, placebo-controlled, two-way crossover trial.","volume":"12","author":"Wu","year":"2024","journal-title":"Lancet Respir Med"},{"key":"R2-20260707","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S2213-2600(22)00251-X","article-title":"Longitudinal lung function and gas transfer in individuals with idiopathic pulmonary fibrosis: a genome-wide association study.","volume":"11","author":"Allen","year":"2023","journal-title":"Lancet Respir Med"},{"key":"R3-20260707","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1038\/s41584-019-0323-6","article-title":"Chemokines in rheumatic diseases: pathogenic role and therapeutic implications.","volume":"15","author":"Miyabe","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"R4-20260707","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1016\/j.chest.2017.05.015","article-title":"Lung manifestations in the rheumatic diseases.","volume":"152","author":"Doyle","year":"2017","journal-title":"Chest"},{"key":"R5-20260707","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/j.semarthrit.2021.07.002","article-title":"MUC5B promoter variant rs35705950 and rheumatoid arthritis associated interstitial lung disease survival and progression.","volume":"51","author":"Juge","year":"2021","journal-title":"Semin Arthritis Rheum"},{"key":"R6-20260707","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1056\/NEJMoa1801562","article-title":"MUC5B promoter variant and rheumatoid arthritis with interstitial lung disease.","volume":"379","author":"Juge","year":"2018","journal-title":"N Engl J Med"},{"key":"R7-20260707","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12931-018-0730-2","article-title":"Idiopathic pulmonary fibrosis: pathogenesis and management.","volume":"19","author":"Sgalla","year":"2018","journal-title":"Respir Res"},{"key":"R8-20260707","doi-asserted-by":"crossref","first-page":"e000366","DOI":"10.1136\/bmjmed-2022-000366","article-title":"Quantifying the impact of unmeasured confounding in observational studies with the E value.","volume":"2","author":"Gaster","year":"2023","journal-title":"BMJ Med"},{"key":"R9-20260707","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1001\/jama.2021.18236","article-title":"Strengthening the reporting of observational studies in epidemiology using Mendelian randomization: the STROBE-MR statement.","volume":"326","author":"Skrivankova","year":"2021","journal-title":"JAMA"},{"key":"R10-20260707","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s43586-021-00092-5","article-title":"Mendelian randomization.","volume":"2","author":"Sanderson","year":"2022","journal-title":"Nat Rev Methods Primers"},{"key":"R11-20260707","doi-asserted-by":"crossref","first-page":"6080","DOI":"10.3390\/jcm13206080","article-title":"Multi-ancestry causal association between rheumatoid arthritis and interstitial lung disease: a bidirectional two-sample Mendelian randomization study.","volume":"13","author":"Kim","year":"2024","journal-title":"J Clin Med"},{"key":"R12-20260707","doi-asserted-by":"crossref","first-page":"100383","DOI":"10.1016\/j.gfs.2020.100383","article-title":"Instrumental variables and the claim of causality: evidence from impact studies in maize systems.","volume":"26","author":"Kubitza","year":"2020","journal-title":"Global Food Security"},{"key":"R13-20260707","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1038\/mp.2016.252","article-title":"Cannabis use and risk of schizophrenia: a Mendelian randomization study.","volume":"23","author":"Vaucher","year":"2018","journal-title":"Mol Psychiatry"},{"key":"R14-20260707","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12890-024-02942-w","article-title":"Exploring the causal relationship between immune cells and idiopathic pulmonary fibrosis: a bi-directional Mendelian randomization study.","volume":"24","author":"He","year":"2024","journal-title":"BMC Pulm Med"},{"key":"R15-20260707","doi-asserted-by":"crossref","first-page":"e143226","DOI":"10.1172\/JCI143226","article-title":"Immune dysregulation as a driver of idiopathic pulmonary fibrosis.","volume":"131","author":"Shenderov","year":"2021","journal-title":"J Clin Invest"},{"key":"R16-20260707","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1136\/thorax-2023-220856","article-title":"Rheumatoid arthritis and idiopathic pulmonary fibrosis: a bidirectional Mendelian randomisation study.","volume":"79","author":"Leavy","year":"2024","journal-title":"Thorax"},{"key":"R17-20260707","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1080\/1744666X.2019.1698293","article-title":"Obstructive lung diseases and risk of rheumatoid arthritis.","volume":"16","author":"Friedlander","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"key":"R18-20260707","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1513\/AnnalsATS.201903-198RL","article-title":"Angiotensin receptor blockers and subclinical interstitial lung disease: the MESA study.","volume":"16","author":"Gannon","year":"2019","journal-title":"Ann Am Thorac Soc"},{"key":"R19-20260707","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/j.chest.2019.12.005","article-title":"IgA antibodies directed against citrullinated protein antigens are elevated in patients with idiopathic pulmonary fibrosis.","volume":"157","author":"Solomon","year":"2020","journal-title":"Chest"},{"key":"R20-20260707","doi-asserted-by":"crossref","first-page":"61","DOI":"10.4078\/jrd.2022.29.2.61","article-title":"Recent advances in basic and clinical aspects of rheumatoid arthritis-associated interstitial lung diseases.","volume":"29","author":"Lee","year":"2022","journal-title":"J Rheum Dis"},{"key":"R21-20260707","doi-asserted-by":"crossref","first-page":"e0286956","DOI":"10.1371\/journal.pone.0286956","article-title":"A meta-analysis of the clinical significance of neutrophil-to-lymphocyte ratios in interstitial lung disease.","volume":"18","author":"Dong","year":"2023","journal-title":"PLoS One"},{"key":"R22-20260707","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41584-018-0070-0","article-title":"Rheumatoid arthritis and the mucosal origins hypothesis: protection turns to destruction.","volume":"14","author":"Holers","year":"2018","journal-title":"Nat Rev Rheumatol"},{"key":"R23-20260707","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.21037\/jtd-20-651","article-title":"Bronchoalveolar lavage as a diagnostic procedure: a review of known cellular and molecular findings in various lung diseases.","volume":"12","author":"Davidson","year":"2020","journal-title":"J Thorac Dis"},{"key":"R24-20260707","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.resinv.2023.05.005","article-title":"Pulmonary fibrosis and type-17 immunity.","volume":"61","author":"Senoo","year":"2023","journal-title":"Respir Investig"},{"key":"R25-20260707","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.3390\/cells10061321","article-title":"Aberrant B cell receptor signaling in na\u00efve B cells from patients with idiopathic pulmonary fibrosis.","volume":"10","author":"Neys","year":"2021","journal-title":"Cells"},{"key":"R26-20260707","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3389\/fmed.2018.00043","article-title":"The role of immune and inflammatory cells in idiopathic pulmonary fibrosis.","volume":"55","author":"Desai","year":"2018","journal-title":"Front Med (Lausanne)"},{"key":"R27-20260707","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s40674-020-00160-z","article-title":"Rheumatoid arthritis-associated interstitial lung disease: current update on prevalence, risk factors, and pharmacologic treatment.","volume":"6","author":"Huang","year":"2020","journal-title":"Curr Treatm Opt Rheumatol"},{"key":"R28-20260707","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1164\/rccm.200404-571OC","article-title":"Double-blind, placebo-controlled trial of pirfenidone in patients with idiopathic pulmonary fibrosis.","volume":"171","author":"Azuma","year":"2005","journal-title":"Am J Respir Crit Care Med"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048543","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T09:00:46Z","timestamp":1783414846000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000048543"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":28,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000048543","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]},"assertion":[{"value":"2026-01-26","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-04-10","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}